|
Market Closed -
Australian S.E.
00:59:32 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.0540 AUD | -3.57% |
|
-6.90% | -35.71% |
| 10-20 | Prescient Therapeutics Limited - Special Call | |
| 10-13 | Prescient Therapeutics Limited - Shareholder/Analyst Call |
Company Valuation: Prescient Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 157.1 | 101.4 | 65.23 | 30.6 | 35.43 | 64.14 |
| Change | - | -35.43% | -35.69% | -53.08% | 15.79% | 81.02% |
| Enterprise Value (EV) 1 | 141.1 | 89.14 | 43.31 | 16.42 | 28.51 | 55.32 |
| Change | - | -36.83% | -51.41% | -62.09% | 73.62% | 94.05% |
| P/E | -36x | -19.6x | -8.41x | -3.71x | -4.84x | -8.94x |
| PBR | 7.69x | 6.05x | 2.5x | 1.69x | 3.11x | 4.52x |
| PEG | - | -1.2x | -0.4x | -0.59x | 0.4x | 0.4x |
| Capitalization / Revenue | 132x | 53.7x | 26.9x | 8.24x | 8.13x | 18.6x |
| EV / Revenue | 119x | 47.2x | 17.8x | 4.42x | 6.54x | 16x |
| EV / EBITDA | -33.3x | -17.1x | -5.81x | -2.29x | -3.78x | -7.87x |
| EV / EBIT | -33.3x | -17.1x | -5.81x | -2.28x | -3.78x | -7.75x |
| EV / FCF | -55.9x | -37.1x | -11.3x | -2.87x | -5.77x | -13.8x |
| FCF Yield | -1.79% | -2.69% | -8.86% | -34.8% | -17.3% | -7.24% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0068 | -0.007899 | -0.009627 | -0.0102 | -0.009099 | -0.006821 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1.185 | 1.889 | 2.428 | 3.712 | 4.356 | 3.451 |
| EBITDA 1 | -4.241 | -5.209 | -7.456 | -7.186 | -7.535 | -7.03 |
| EBIT 1 | -4.242 | -5.21 | -7.458 | -7.186 | -7.536 | -7.14 |
| Net income 1 | -4.149 | -5.117 | -7.005 | -8.238 | -7.323 | -7.003 |
| Net Debt 1 | -15.95 | -12.28 | -21.92 | -14.18 | -6.927 | -8.825 |
| Reference price 2 | 0.2450 | 0.1550 | 0.0810 | 0.0380 | 0.0440 | 0.0610 |
| Nbr of stocks (in thousands) | 641,053 | 654,323 | 805,270 | 805,320 | 805,320 | 1,051,515 |
| Announcement Date | 8/30/21 | 8/22/22 | 8/24/23 | 8/25/24 | 8/20/25 | 8/20/26 |
1AUD in Million2AUD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 43.44M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 7.93x | 26.43x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 32.66x | 5.97x | 20.09x | -.--% | 23.67B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| Average | 26.77x | 26.45x | 15.70x | 0.32% | 38.32B | |
| Weighted average by Cap. | 26.72x | 25.32x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PTX Stock
- Valuation Prescient Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
